Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/2000
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/29/2000EP0988797A1 Compositions for postgastrectomic mineral supply
03/29/2000EP0988377A1 Zinc finger protein derivatives and methods therefor
03/29/2000EP0988316A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988282A2 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
03/29/2000EP0988056A2 Tissue factor methods and compositions for coagulation and tumor treatment
03/29/2000EP0886526A4 Protection of hemopoietic cells
03/29/2000EP0783320A4 Protection of hemopoietic cells during chemotherapy or radiotherapy
03/29/2000EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
03/29/2000CN1050845C Compound Leustroducsin H, its use in medicine preparation and medicinal compositions having same
03/29/2000CN1050830C Hydroxy-substituted azetidinone compounds and its use in medicine
03/29/2000CN1050755C Traditional Chinese medicine for treating bleeding disease and preparation process thereof
03/28/2000US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof
03/28/2000US6043215 Preparation of factor IX
03/28/2000US6043056 Amino acid sequences; for diagnosis, treatment, and prevention of blood, karyotypic, and nervous system disorders
03/28/2000CA2164712C Trifunctional antithrombin and antiplatelet peptides
03/28/2000CA2004885C Anticoagulant peptides
03/28/2000CA2004739C Hemostatic collagen paste composition
03/28/2000CA2002144C Method of preventing or reducing eosinophilia
03/23/2000WO2000015800A2 Rac-like genes and methods of use
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015794A1 Human cell junction pdz protein
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015658A1 FACTOR VIIa INHIBITORS
03/23/2000WO2000015639A1 Carboline derivatives as cgmp phosphodiesterase inhibitors
03/23/2000WO2000015614A1 Novel compounds
03/23/2000WO2000015250A2 Fibroblast inhibitor
03/23/2000WO2000015244A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
03/23/2000WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF
03/23/2000DE19842415A1 Pharmaceutical preparation for treating e.g. tumors, thrombosis or inflammation, contains cyclic pentapeptide integrin inhibitor and chemotherapeutic agent and/or angiogenesis inhibitor
03/23/2000CA2344151A1 Pharmaceutical preparation
03/23/2000CA2344048A1 Factor viia inhibitors
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342301A1 Human cell junction pdz protein
03/23/2000CA2341440A1 Novel compounds
03/22/2000EP0987274A1 Factor VIIa Inhibitors
03/22/2000EP0987253A1 Pyrazolone derivatives
03/22/2000EP0986580A1 Oligosaccharide mixtures having antithrombotic activity
03/22/2000EP0986551A1 Sulfonamide derivatives, their production and use
03/22/2000EP0986391A1 Oxyalkylene phosphate compounds and uses thereof
03/22/2000EP0986376A1 COMPOSITIONS FOR TREATING AND PREVENTING ARTERIAL THROMBOSIS AND USE OF A FACTOR Xa INHIBITOR ON ITS OWN AND/OR COMBINED WITH A PLATELET ANTIAGGREGATING AGENT
03/22/2000CN1248251A Disubstituted bicyclic heterocycles, their production and use as medicaments
03/22/2000CN1247759A Hemiplegia treating pill
03/21/2000US6040441 Isolated recombinant cdna which encodes a protein having one or more cysteine containing domains; for diagnosis and therapy
03/21/2000US6040341 Compounds and their compositions having anti-inflammatory and anti-thrombotic activities
03/21/2000US6040317 Sulfonamide fibrinogen receptor antagonists
03/21/2000US6039945 Administering purified prothrombinase factor to humans
03/21/2000CA2027743C Diuresis by cyclodextrins and their derivatives
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6
03/16/2000WO2000014110A1 CRYSTALLINE FORMS OF EtO2C-CH2-(R)Cgl-Aze-Pab-OH
03/16/2000WO2000014054A1 Unsaturated hydroximic acid derivatives as parp inhibitors
03/16/2000WO2000013707A1 Preventives/remedies for multiple organ failure
03/16/2000WO2000013706A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/16/2000WO2000013703A2 Methods of treating hypertension and compositions for use therein
03/16/2000WO2000013702A2 Use of an angiogenic factor for the treatment of microvascular angiopathies
03/16/2000WO2000013696A1 Composition for improving mental capabilities in mammals
03/16/2000WO2000013671A1 Immediate release tablet
03/16/2000WO2000008014A8 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000CA2342898A1 Unsaturated hydroximic acid derivatives as parp inhibitors
03/16/2000CA2342796A1 Preventives/remedies for multiple organ failure
03/16/2000CA2342280A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/16/2000CA2341259A1 Crystalline forms of eto2c-ch2-(r)cgl-aze-pab-oh
03/16/2000CA2306165A1 Composition for improving mental capabilities in mammals
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984934A1 Novel orally active iron (iii) chelators
03/15/2000EP0984787A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
03/15/2000EP0984785A1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
03/15/2000EP0656008B1 Thrombin receptor antagonists
03/15/2000EP0549702B1 Use of recombinant colony stimulating factor-1
03/15/2000CN1247543A Cyclic peptide derivatives
03/15/2000CN1247531A Arylsulfonyl hydroxamic acid derivatives
03/15/2000CN1050283C Gel-type cosmetic composite
03/14/2000US6037488 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
03/14/2000US6037376 Methods for therapy of cancer
03/14/2000US6037356 Anticoagulants; antiinflammatory and antiarthritic agents
03/14/2000US6037343 Fibrinogen receptor antagonists
03/14/2000US6037334 Inhibitors of factor xa that can be used to prevent diseases such asthrombosis, apoplexy, coronary infarction, inflammations, and arteriosclerosis
03/14/2000US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues
03/14/2000US6037322 Beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke; administered by continuous infusion
03/14/2000US6036958 Tsetse thrombin inhibitor
03/14/2000US6036955 Antitumor agents
03/14/2000CA2098483C Safe adeno-associated virus 2 vector for gene therapy
03/14/2000CA2008263C Pyrazolopyridine compound and processes for preparation thereof
03/09/2000WO2000012741A2 Inducible expression system
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012683A2 Stem cells bearing an fgf receptor on the cell surface
03/09/2000WO2000012562A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012532A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses
03/09/2000WO2000012504A2 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012481A2 Indazole derivatives with 5-ht2 receptor activity________________
03/09/2000WO2000012479A1 2-oxo-2h-quinoline derivatives
03/09/2000WO2000012475A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000WO2000012108A1 Dry extract of henna, method for producing said extract and use of the same
1 ... 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 ... 671